The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis
Open accessThe DOI matches its Crossref record; 66 of the 67 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The effects of systolic blood pressure (SBP), serum total cholesterol (TC), fasting plasma glucose (FPG), and body mass index (BMI) on the risk of cardiovascular diseases (CVD) have been established in epidemiological studies, but consistent estimates of effect sizes by age and sex are not available. METHODS: We reviewed large cohort pooling projects, evaluating effects of baseline or usual exposure to metabolic risks on ischemic heart disease (IHD), hypertensive heart disease (HHD), stroke, diabetes, and, as relevant selected other CVDs, after adjusting for important confounders. We pooled all data to estimate relative risks (RRs) for each risk factor and examined effect modification by age or other factors, using random effects models. RESULTS: Across all risk factors, an average of 123 cohorts provided data on 1.4 million individuals and 52,000 CVD events. Each metabolic risk factor was robustly related to CVD. At the baseline age of 55-64 years, the RR for 10 mmHg higher SBP was largest for HHD (2.16; 95% CI 2.09-2.24), followed by effects on both stroke subtypes (1.66; 1.39-1.98 for hemorrhagic stroke and 1.63; 1.57-1.69 for ischemic stroke). In the same age group, RRs for 1 mmol/L higher TC were 1.44 (1.29-1.61) for IHD and 1.20 (1.15-1.25) for ischemic stroke. The RRs for 5 kg/m(2) higher BMI for ages 55-64 ranged from 2.32 (2.04-2.63) for diabetes, to 1.44 (1.40-1.48) for IHD. For 1 mmol/L higher FPG, RRs in this age group were 1.18 (1.08-1.29) for IHD and 1.14 (1.01-1.29) for total stroke. For all risk factors, proportional effects declined with age, were generally consistent by sex, and differed by region in only a few age groups for certain risk factor-disease pairs. CONCLUSION: Our results provide robust, comparable and precise estimates of the effects of major metabolic risk factors on CVD and diabetes by age group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the risk of CVD increases continuously with rising fasting plasma glucose levels, even before reaching levels sufficient for a diabetes diagnosis [5].”
From Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 (2018) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Self-citation(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266
Self-citationTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · cited 1×
“For BMI and FPG, confounding remains a concern as evidence from randomized trials of disease outcomes is either very limited for practical reasons (BMI) or provides mixed results (FPG) [49–52].”
BackgroundBariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800 · cited 14×
“Metabolic risk factors We compared and pooled RRs for the effects of key metabolic risk factors: SBP, TC, FPG, and adiposity measured by BMI, from major global pooling projects.”
BackgroundInfluentialCholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Research works printed but not linked: 2
- James WPT, Jackson-Leach R, Ni Mhurchu C, Kalamara E, Shayeghi M, <etal>et al</etal>.. (2004) Overweight and obesity (high body mass index). In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks. Geneva: World Health Organization. pp. 497–596.
- Lawes CM, Vander Hoorn S, Law MR, Elliott P, MacMahon S, <etal>et al</etal>.. (2004) High Blood Pressure. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks. Geneva: World Health Organization. pp. 497–596.
Cited by
Items 401–500 of 772
Correlates of obesity indices and cardiovascular disease risk factors among Trinidadian nurses
Donkor, N., Farrell, K., Ocho, O. N., Sheppard, C., Caesar, L. A., Andrews, L., Modeste, S., Otieno, P. O., & Acquah, S. (2020) · International Journal of Africa Nursing Sciences · doi:10.1016/j.ijans.2020.100194 · Cited by 10
Andrews, R. M., Shpitser, I., López, O. L., Longstreth, W. T., Jr., Chaves, P. H. M., Kuller, L. H., & Carlson, M. C. (2020) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.1111/rssa.12570 · Cited by 11
“Other studies have demonstrated that diabetics have higher cardiovascular burden, including brain lesions, that can possibly co-occur with cognitive impairment (Falvey et al., 2013; Kooistra et al., 2013; Luchsinger et al., 2007; Manschot et al., 2006; Singh et al., 2013).”
BackgroundLi, Z., Wang, W., Tian, X., Duan, H., Xu, C., & Zhang, D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246436 · Cited by 11
Talukder, A., Gupta, R. D., Hashan, M. R., Haider, S. S., Sajal, I. H., & Sarker, M. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045547 · Cited by 37
Body mass index and stroke risk among patients with diabetes mellitus in Korea
Song, D. K., Hong, Y. S., Sung, Y., & Lee, H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275393 · Cited by 14
“Obesity and diabetes mellitus (DM) are both associated with an increased risk of cardiovascular disease, including ischemic heart disease and stroke, which are the leading causes of death [1, 2].”
Hypertension and medical expenditure in the Japanese population: Review of prospective studies
Nakamura, K. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i7.531 · Cited by 10
Cho, Y., Cudhea, F., Park, J., Lee, J.-T., Mozaffarian, D., Singh, G. M., & Shin, M. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-013283 · Cited by 10
“TMRED values were obtained from the literature.(16) 25 The TMRED for risk factors with protective effects was defined as the intake levels at which they had beneficial effects (eg, a high intake of fruit, vegetables and whole grains).”
InfluentialSelf-citationEffect of Roux-en-Y gastric surgery on ciprofloxacin pharmacokinetics: an obvious effect?
Rivas, A. B., Picado, A. L., Salas-Butrón, M. R., Terleira, A. I., Sánchez-Pernaute, A., García, A. J. T., Lopera, C. M., Chicharro, L. M., Bandrés, F., Rubio, M. Á., et al. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-018-02623-8 · Cited by 10
Dipeptidyl peptidase-4 inhibitors as new tools for cardioprotection
Rankovic, M. R., Jeremic, N. S., Srejovic, I. M., Radonjić, K., Stojanović, A., Glišić, M., Bolevich, S. S., Bolevich, S., & Jakovljevic, V. L. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-10005-5 · Cited by 11
Huang, A., Lin, B., Jia, Z., Ji, X., & Chen, Y. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1416836 · Cited by 10
Zilli, A. M. H., & Zilli, E. M. (2021) · Protein and Peptide Letters · doi:10.2174/0929866528666210127152359 · Cited by 10
Shemirani, F., Golzarand, M., Salari-Moghaddam, A., & Mahmoudi, M. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1871588 · Cited by 9
“This overwhelming health issue is a major risk factor for many metabolic disorders such as insulin resistance, diabetes mellitus and cardiovascular diseases (Singh et al. 2013).”
BackgroundImpact of Bariatric Surgery on Endometrial Cancer Tumor Pathology
Mahvi, D. A., Foley, O., Ardestani, A., Tavakkoli, A., & Sheu, E. G. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05294-0 · Cited by 9
Lange, E., Kęszycka, P. K., Pałkowska-Goździk, E., & Billing-Marczak, K. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191912117 · Cited by 9
“One of the most severe metabolic complications of excessive body weight is diabetes type 2 [2].”
BackgroundWang, B., Jin, Y., Li, J., Yang, F., Lü, H., Zhou, J., Liu, S., Shen, Z., Yu, X., & Yuan, T. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2023.139883 · Cited by 9
Zhou, X., Hao, R., Zhu, X., Tan, X., & Li, D. (2024) · Food Frontiers · doi:10.1002/fft2.379 · Cited by 9
Wang, L., Zhang, W., Dai, J., Deng, Q., Yan, Y., & Liu, Q. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14196 · Cited by 11
“More than half of people with type 2 diabetes die due to vascular complications, such as myocardial infarction (MI) and stroke 3 , and cardiovascular (CV) disease (CVD) risk increases with higher FPG levels 4 .”
BackgroundCobiac, L. J., Law, C., Smith, R., Cummins, S., Rutter, H., Rayner, M., Mytton, O. T., Briggs, A. D. M., Jensen, H. T., Keogh-Brown, M. R., et al. (2025) · Public Health Research · doi:10.3310/gjmw1501 · Cited by 11
Kulaeva, E. D., Volchik, V. V., Bocharova, O. V., Teplyakova, E. D., Алексеевич, Ш. М., Derevyanchuk, E. G., & Mashkina, E. V. (2021) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2020.0343 · Cited by 9
“This disease causes not only psychophysical discomfort but also causes other health problems, such as cardiovascular diseases, diabetes, and high blood pressure (Hsu et al. , 2006; Li et al. , 2006; Singh et al. , 2013).”
Carrillo-Larco, R. M., Stern, D., Hambleton, I. R., Hennis, A. J. M., Cesare, M. D., Lotufo, P. A., Ferreccio, C., Irazola, V. E., Perel, P., Gregg, E. W., et al. (2021) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2021.100068 · Cited by 15
“4 ostly conducted in high-income countries ( Figure 3 ) [5] .”
InfluentialSelf-citationGuzman‐Vilca, W. C., & Carrillo-Larco, R. M. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002673 · Cited by 10
“16 Moreover, these global estimates were based on risk estimates from North America, Europe, and Asia, 17 which may not represent the epidemiological scenario in LAC.”
Nakamura, H., Kawashima, T., Yamasaki, L., Lwin, K. S., Eguchi, A., Hayabuchi, H., Tanoe, Y., Tanaka, S., Yoneoka, D., Ghaznavi, C., et al. (2022) · Food Science & Nutrition · doi:10.1002/fsn3.3121 · Cited by 12
“…the risk of cardiovascular diseases (Bibbins- Domingo et al., 2010; British Heart Foundation, 2022; Brown et al., 2009; Cogswell et al., 2016; Singh et al., 2013; Thomopoulos et al., 2014), chronic kidney disease (Xie et al., 2016), and gastric cancer (D'Elia et al., 2012; World Cancer…”
BackgroundObesity Paradox in Off-Pump Coronary Artery Bypass Surgery: Does It Benefit the Elderly?
Badrudin, D., Khaliel, F. H., & Cartier, R. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.05.005 · Cited by 10
Giráldez‐García, C., Franch‐Nadal, J., Sangrós, F. J., Ruíz, A., Carramiñana, F., Goday, A., Villaró, M., Soidán, F. J. G., Serrano, R., Regidor, E., et al. (2018) · Obesity · doi:10.1002/oby.22256 · Cited by 10
“However, these studies provide evidence limited to general adiposity measures (17), people 65 years and older (18), or Japanese American adults (19).”
BackgroundJo, G., Oh, H., Singh, G. M., Park, D., & Shin, M. (2020) · Nutrition Research and Practice · doi:10.4162/nrp.2020.14.4.384 · Cited by 10
Self-citationEnomoto, A., Saito, A., Takahashi, O., Kimura, T., Tajima, R., Rahman, M., & Iida, K. (2020) · Health Education & Behavior · doi:10.1177/1090198120919675 · Cited by 10
“High body mass index (BMI) is an important risk factor for chronic diseases such as cardiovascular diseases (Lu et al., 2014; Ni Mhurchu et al., 2004; Singh et al., 2013; Whitlock et al., 2009) and diabetes (Whitlock et al., 2009).”
BackgroundWang, M., Geng, X., Li, K., Wang, Y., Duan, X., Hou, C., Zhao, L., Zhou, H., & Zhao, D. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03667-1 · Cited by 10
“Obesity is a risk factor for developing many disorders, such as diabetes mellitus, hypertension, and cardiovascular events [2].”
BackgroundKwon, H.-S., Kim, S.-J., Shin, K. J., Kim, S. H., Yun, J., Bae, J., Tak, H.-J., Lee, N., & Kim, H.-J. (2024) · Nutrients · doi:10.3390/nu16131993 · Cited by 12
“Previous studies have revealed an association between high BMI and chronic diseases, such as diabetes mellitus [3], cardiovascular disease [4], obstructive sleep apnea–hypopnea syndrome [5], knee osteoarthritis [6], nonalcoholic fatty liver disease [7], and chronic kidney disease [8].”
BackgroundJo, J., Ha, N., Ji, Y., Ra, A., Seo, J. H., Oh, B., Choi, S., Choe, E. K., Lee, W., Son, J. W., et al. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae389 · Cited by 9
Luo, Y., Zhang, J., & Guo, H. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-088363 · Cited by 9
Chapela, S. P., Locatelli, J., Saettone, F., Forte, C., Memoli, P., Cucalón, G., Ceriani, F., Sarno, G., Coppola, L., & Frías-Toral, E. (2025) · Food and Agricultural Immunology · doi:10.1080/09540105.2025.2490003 · Cited by 9
“Chronic low-grade inflammation has been established to be involved in a wide range of pathologies such as cancer, cardiovascular diseases, diabetes, arthritis, Alzheimer’s, lung and autoimmune diseases (Lauby-Secretan et al., 2016; Singh et al., 2013).”
Impact of COVID-19 pandemic on obesity among adults in Jordan
Rababah, T., Alu'datt, M. H., Angor, M., Gammoh, S., Rababah, R., Magableh, G. M., Almajwal, A. M., AL‐Rayyan, Y., & AL‐Rayyan, N. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1114076 · Cited by 9
Collecting health-related research data using consumer-based wireless smart scales
Johannessen, E., Johansson, J., Hartvigsen, G., Horsch, A., Årsand, E., & Henriksen, A. (2023) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2023.105043 · Cited by 9
Kono, M., Shatila, M., Xu, G., Lu, Y., Mathew, A., Mohajir, W., Varatharajalu, K., Qiao, W., Thomas, A. S., & Wang, Y. (2023) · Cancers · doi:10.3390/cancers15082329 · Cited by 8
Utilidad del índice de masa corporal en pacientes con enfermedad renal crónica
Raventos, M. E. P., Rubio, A. R., & Coloma, R. A. (2017) · Enfermería Nefrológica · doi:10.4321/s2254-28842017000400005 · Cited by 13
Dong, W., Wan, E. Y. F., Bedford, L. E., Wu, T., Wong, C. K. H., Tang, E. H. M., & Lam, C. L. K. (2020) · Public Health · doi:10.1016/j.puhe.2020.06.020 · Cited by 9
Obesity Is Associated with Increased F2-Isoprostanes and IL-6 in Black Women
Saleem, M., Kastner, P. D., Mehr, P. E., Milne, G. L., Ishimwe, J., Park, J., Shibao, C. A., & Kirabo, A. (2023) · Endocrines · doi:10.3390/endocrines4010003 · Cited by 10
Weight Management for Athletes: Important Things to be Considered
Odysseos, C., & Avraamidou, M. (2017) · Arab Journal of Nutrition and Exercise (AJNE) · doi:10.18502/ajne.v1i3.1232 · Cited by 11
Cho, Y., Cudhea, F., Park, J., Mozaffarian, D., Singh, G. M., & Shin, M. (2017) · Yonsei Medical Journal · doi:10.3349/ymj.2017.58.3.540 · Cited by 10
“Relative risk (RR) for causal relationship between risk factors and diseases was obtained from published systematic reviews and meta-analyses of epidemiological studies.(12,13) We used cause-specific death number from national mortality surveillance report collected by Statistics Korea (KOSIS).”
MethodSelf-citationEffectiveness of Dietary Policies to Reduce Noncommunicable Diseases
Afshin, A., Micha, R., Webb, M., Capewell, S., Whitsel, L. P., Rubinstein, A. L., Prabhakaran, D., Suhrcke, M., & Mozaffarian, D. (2017) · Europe PMC (PubMed Central) · doi:10.1596/978-1-4648-0518-9/ch6 · Cited by 12
Self-citationSharma, S., Aziz, M., Vohra, I., Kamal, F., Acharya, A., Khan, Z. H., Weissman, S. I., & Nawras, A. T. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04884-8 · Cited by 8
Jahangiri, M., Shahrbanian, S., & Hackney, A. C. (2021) · PubMed · doi:10.22034/jchr.2021.1935792.1361 · Cited by 11
Methods needed to measure predictive accuracy: A study of diabetic patients
Khan, H. M. R., Mende, S., Rafiq, A., Gabbidon, K., & Reddy, P. H. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.01.007 · Cited by 8
Al-Sabah, S. K., Elshamy, A., Jois, S., Low, K., Gras, A., & Gulnar, E. P. (2023) · Journal of Medical Economics · doi:10.1080/13696998.2023.2265721 · Cited by 7
“Epidemiologic studies identified high body-mass index (BMI) as a risk factor for type 2 diabetes mellites (T2DM) 17–19 , CVD, which include heart failure, angina, hypertension, atrial fibrillation and hyperlipidemia 17–21 , sleep apnea 18,19,22 , osteoarthritis 19,23,24 , asthma 18,19 , and chronic kidney disease (CKD…”
InfluentialMeshram, I., Balakrishna, N., Bhaskar, V., Laxmaiah, A., Brahmam, G. N. V., & Arlappa, N. (2025) · BMC Public Health · doi:10.1186/s12889-025-23731-y · Cited by 7
Blood-based obesity biomarkers and their relevance for disease risk
Pischon, T., & Nimptsch, K. (2026) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01229-2 · Cited by 7
Baroni, I., Caruso, R., Dellafiore, F., Arrigoni, C., Fabrizi, D., Luciani, M., Rebora, P., & Ausili, D. (2022) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2022.03.009 · Cited by 7
Pediatric obesity and anesthetic challenges of metabolic surgery
Hashim, A., Sedky, M. K., Masood, W., Shehata, I. M., & Kaye, A. D. (2022) · Saudi Journal of Anaesthesia · doi:10.4103/sja.sja_469_22 · Cited by 7
“445 Saudi Journal of Anesthesia / Volume 16 / Issue 4 / October-December 2022 multiple health‐related conditions, including cardiovascular incidents, diabetes mellitus, cancer, and many other pathophysiological processes.[3,4] Additionally, obesity carries a significant economic burden on afflicted families.”
BackgroundChen, X., Li, H., Liu, B., Wang, X., Zhou, W., Wu, G., & Xu, C. (2023) · PubMed Central · Cited by 13
Rural-urban differentials in child body mass index over time
Wake, S. K., Zewotir, T. T., Mekebo, G. G., & Fissuh, Y. H. (2023) · BMC Pediatrics · doi:10.1186/s12887-023-04241-5 · Cited by 8
Exenatide for obesity in children and adolescents: Systematic review and meta-analysis
李熙鸿, Chen, B., Xiao, D., Zou, Z., & Zhang, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1290184 · Cited by 9
Xu, W., Feng, Y., Abdullah, G., Li, L., Fang, P., Tang, S., Yang, H., Kong, D., Huang, H., Wang, Y., et al. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1376463 · Cited by 8
“A meta-analysis pooling data from a large cohort revealed that among participants aged 55 – 64 years, each 1 mmol/L increase in FPG was linked to relative risks (RRs) of 1.18 (95% CI 1.08 – 1.29) for ischemic heart disease and 1.14 (95% CI 1.01 – 1.29) for stroke (25).”
InfluentialChao, T.-H., Lin, T., Cheng, C., Wu, Y., Ueng, K., Wu, Y., Lin, W.-W., Leu, H.-B., Cheng, H., Huang, C., et al. (2024) · PubMed Central · doi:10.6515/acs.202409_40(5).20240724a · Cited by 18
Evans, A. J., & Li, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212464 · Cited by 9
Reddy, C. S. S. (2022) · Bioinformation · doi:10.6026/97320630018337 · Cited by 7
Yamada, K., Tanaka, T., Kai, K., Matsufuji, S., Ito, K., Kitajima, Y., Manabe, T., & Noshirο, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411546 · Cited by 7
“Obesity has become a prominent health concern worldwide as a risk factor for several chronic diseases, including diabetes mellitus, cardiovascular disease, and chronic kidney disease [1,2].”
BackgroundZhang, Y., Abdin, E., Sambasivam, R., Shafie, S., Roystonn, K., Vaingankar, J. A., Chong, S. A., & Subramaniam, M. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1374806 · Cited by 8
Farzadfar, F., Peykari, N., Moghaddam, S. S., Djalalinia, S., Kasaeian, A., Sheidaei, A., Mansouri, A., Mohammadi, Y., Parsaeian, M., Mehdipour, P., et al. (2016) · International Journal of Preventive Medicine · doi:10.4103/2008-7802.182732 · Cited by 7
“Identifying peoples who needed intervention even based on the presence of a single risk factor could promote the results of years of life lost index.[19-21] Evidence shows that in diabetic patients, reduction of the FPG levels to Figure 5: The national population attributable fractions of the effect of high fasting pl…”
BackgroundSelf-citationSystolic Blood Pressure and Vascular Disease in Men Aged 65 Years and Over
Lacey, B., Golledge, J., Yeap, B. B., Lewington, S., McCaul, K. A., Norman, P. E., Flicker, L. A., Almeida, O. P., & Hankey, G. J. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09150 · Cited by 7
Self-citationLee, D., Yoo, J.-H., & Lee, B.-C. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/8159261 · Cited by 7
“Obesity results in the progression of metabolic disorders, especially type 2 diabetes (T2DM).”
BackgroundInfluentialSom, C., & Venkataramana, N. K. (2018) · Journal of Pre-Clinical and Clinical Research · doi:10.26444/jpccr/85329 · Cited by 7
Increased body mass index is a risk factor for acute promyelocytic leukemia
Kashanian, S. M., Li, A. Y., Ali, M. K. M., Sutherland, M. E., Duong, V. H., Hambley, B. C., Zacholski, K., Chaer, F. E., Holtzman, N. G., Imran, M., et al. (2021) · eJHaem · doi:10.1002/jha2.163 · Cited by 7
Self-citationRole of Ventromedial Hypothalamus in Sucrose-Induced Obesity on Metabolic Parameters
Archana Gaur, T., Pal, G. K., & Pal, P. (2021) · Annals of Neurosciences · doi:10.1177/09727531211005738 · Cited by 8
Blakstad, M. M., Fawzi, W. W., Castro, M. C., Thompson, A., Arabi, M., & Danaei, G. (2022) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac214 · Cited by 7
Self-citationCanine Obesity: Contributing Factors and Body Condition Evaluation
Ramos, A. G. D. C., Morais, K. M. A. D. S. C., Lima, N. D. D. S., Umigi, R. T., de Paiva, J. T., & Fagundes, G. M. (2025) · Pets · doi:10.3390/pets2020022 · Cited by 6
Motuma, A., Mussa, I., DERESSA, A. D., Regassa, L. D., & Birhanu, A. (2025) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2025.100965 · Cited by 10
Obeegadoo, I., Luo, R., Pelland-St-Pierre, L., Dugandzic, R. M., Donaldson, S. G., Hayes, S., Cakmak, S., & Larsen, K. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.181134 · Cited by 7
Web-based cardiovascular disease risk prediction using machine learning
Akhter, S., & Miller, J. H. (2026) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2026.1690664 · Cited by 6
Genetic architecture of obesity and advances in precision pharmacotherapy: a comprehensive review
Kavaja, F., Liehr, T., & Temaj, G. (2026) · Acta Biochimica Polonica · doi:10.3389/abp.2026.15484 · Cited by 6
“Obesity is associated with multiple comorbidities, including various diseases such as cardiovascular disease (Singh et al., 2013), type 2 diabetes (Singh et al., 2013), non-alcoholic fatty liver disease (Li et al., 2016), and high blood pressure (Wang and Wang, 2004).”
Secular trends in serum lipid profiles in young adults in Norway, 2001-19
Arnesen, E., & Retterstøl, K. (2022) · Atherosclerosis Plus · doi:10.1016/j.athplu.2022.03.006 · Cited by 7
“2 for ischaemic heart disease (IHD) in 35e44 year-olds [37].”
BackgroundNing, F., Zhao, J., Zhang, L., Wang, W., Sun, X., Song, X., Zhang, Y., Xin, H., Gao, W., Gao, R., et al. (2023) · Nutrition Research and Practice · doi:10.4162/nrp.2023.17.4.780 · Cited by 6
“Experimental studies have also showed that the mechanisms of fetal programming on insulin resistance and insulin secretion contribute to sex differences in glucose tolerance [16,17].”
BackgroundDong, W., Wang, Y., & Fan, S. (2025) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-025-04788-3 · Cited by 8
Su, S., Lee, W., Chen, T., Wang, H., Su, T., Jeng, J., Tu, Y., Liao, S., Lu, T., & Chien, K. (2017) · Heart Asia · doi:10.1136/heartasia-2017-010905 · Cited by 7
“hyperlipidaemia and diabetes, and were taken from the study by Singh and colleagues.(17) The relative risk for smoking in”
BackgroundUncoupling Protein 2 Expression Modulates Obesity in Chronic Kidney Disease Patients
Shawky, S. A., Gaber, O. A., Mostafa, E., & Sarhan, W. M. (2021) · Reports of Biochemistry and Molecular Biology · doi:10.52547/rbmb.10.1.119 · Cited by 6
“It increases the risk for developing many disease conditions, such as cardiovascular diseases, diabetes mellitus (6,7), various cancers (8), an array of musculoskeletal disorders (9), and poor mental health (10), all of which have negative effects on the quality of daily life, productivity, and healthcare costs.”
Clark, S. N., Bennett, J. E., Arku, R. E., Hill, A. G., Fink, G., Adanu, R., Biritwum, R. B., Darko, R., Bawah, A. A., Duda, R. B., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003850 · Cited by 8
“Elevated blood pressure (BP) and body-mass index (BMI) are important risk factors for noncommunicable diseases (NCDs), such as cardiovascular diseases (CVDs), diabetes, kidney disease, and dementia [1,2], and responsible for substantial burden of NCDs [3].”
BackgroundSelf-citationXiao, W., Wumaer, A., Maimaitiwusiman, Z., Liu, J., Xuekelati, S., & Wang, H. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058400 · Cited by 6
Methenitis, S. K., Feidantsis, K. G., Kaprara, A., Hatzitolios, A. I., Skepastianos, P., Papadopoulou, S. Κ., & Panayiotou, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11206057 · Cited by 6
“However, at least to our knowledge, this hypothesis remains unexamined, particularly in middle-aged males, who are more likely to develop chronic cardiovascular diseases compared to young and elderly males [47].”
BackgroundPractical Application of a New Cuffless Blood Pressure Measurement Method
Gogiberidze, N. A., Suvorov, А. Y., Sultygova, E. A., Sagirova, Z. N., Kuznetsova, N., Gognieva, D. G., Chomakhidze, P. S., Фролов, В. А., Aa, B., Фератовна, М. Д., et al. (2023) · Pathophysiology · doi:10.3390/pathophysiology30040042 · Cited by 7
Looking again at the Look AHEAD study
Gregg, E. W., & Wing, R. R. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30238-3 · Cited by 8
Peng, Y., & Wang, Z. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100369 · Cited by 6
“The decreasing effects of high BMI [13], elevated BP [13,14], and elevated FPG [13,15] with age were also noticed in a few observational studies.”
BackgroundDing, L., Zhuo, C., Fan, Y., Zhang, Y., Li, H., Qi, D., Tang, S., Cui, J., He, Q., & Liu, M. R. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028430 · Cited by 7
“dIsCussIOn Obesity is an important risk factor for type 2 diabetes mellitus, and bariatric surgery is effective in inducing weight-loss and resolution of obesity-related comorbidities.(36) Bariatric surgeries are growing worldwide, but are still underused.”
BackgroundBaghbaninaghadehi, F., Armijo-Olivo, S. L., Prado, C. M. M., & Woodhouse, L. J. (2022) · The Journal of Knee Surgery · doi:10.1055/s-0042-1742646 · Cited by 6
Type 2 diabetes and cardiorenal syndromes. A nationwide French hospital cohort study
Maisons, V., Halimi, J., Fauchier, G., de Fréminville, J.-B., Goin, N., Gueguen, J., Gatault, P., Sautenet, B., Angoulvant, D., Herbert, J., et al. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2023.101441 · Cited by 7
Aplicação do modelo outcome present state test em paciente com insuficiência cardíaca congestiva
Gonçalves, L. W. P., & Pompeo, D. A. (2017) · Reme Revista Mineira de Enfermagem · doi:10.5935/1415-2762.20160047 · Cited by 9
Thisted, L., Østergaard, M. V., Pedersen, A. A., Pedersen, P. J., Lindsay, R. T., Murray, A. J., Fink, L. N., Pedersen, T. X., Secher, T., Johansen, T. T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73046-8 · Cited by 7
The role of body mass index on quality indicators following minimally-invasive radical prostatectomy
Pathak, R. A., Wilson, R. R. A., Craven, T. E., Matz, E., & Hemal, A. K. (2021) · Korean journal of urology · doi:10.4111/icu.20200411 · Cited by 7
“Hypertension, CVD, T2DM, and a variety of malignancies have been shown to have an increased prevalence in patients who are obese [7,16,17].”
BackgroundDamen, J. A. (2016) · BMJ · doi:10.1136/bmj.i4485 · Cited by 6
Lin, Y., Hung, Y., Chen, J., Sung, J., Hsu, M., Dinh, H. K., Chen, K., & Chen, C. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16647 · Cited by 5
Perezalonso-Espinosa, J., Ramírez‐García, D., Díaz-Sánchez, J. P., Carrillo-Herrera, K. B., Cabrera-Quintana, L. A., Dávila-López, G., Fermín‐Martínez, C. A., Liceaga, A. M., Basile‐Alvarez, M. R., Berumen-Campos, J., et al. (2026) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2026.101403 · Cited by 5
“27,28 However, absolute risks may vary substantially due to geographic variation in risk factor levels, which typically reflect underlying epidemiological and socioeconomic patterns within a given population.”
Mendelian randomization: estimation of inpatient hospital costs attributable to obesity
Dick, K. J., Schneider, J. E., Briggs, A. H., Lecomte, P., Régnier, S. A., & Lean, M. E. J. (2021) · Health Economics Review · doi:10.1186/s13561-021-00314-2 · Cited by 6
Munir, M., Azab, S. M., Bangdiwala, S. I., Kurmi, O., Doiron, D., Brook, J. R., Banfield, L. E., & de Souza, R. J. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080026 · Cited by 5
Microsurgical Breast Reconstruction can be Performed Safely in Patients with Obesity
Silverstein, M., Sorice-Virk, S. C., Wan, D. C., & Momeni, A. (2024) · Journal of Reconstructive Microsurgery · doi:10.1055/s-0044-1787266 · Cited by 5
Carnevale, S., Vitale, A., Razzi, M., Onori, C., Cornacchia, G., Grispo, O., Corsinovi, E., Rossl, L., Spinetti, E., Tosi, M., et al. (2024) · Dietetics · doi:10.3390/dietetics3040039 · Cited by 5
Zhao, M., Zheng, Y., & Chen, Z. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1589250 · Cited by 6
Vo, T. T., & Le, Q.-D. (2025) · BMC Public Health · doi:10.1186/s12889-025-23637-9 · Cited by 6
“Overweight and obesity have become significant global health burdens [1–4], contributing to the onset of numerous chronic diseases such as type 2 diabetes [5, 6], cardiovascular diseases [5, 7], osteoarthritis [8, 9], and certain cancers [10–13].”
Betancourt, L. G. M., Marín, J. C. C., & Narváez-Solarte, W. V. (2021) · Hacia la Promoción de la Salud · doi:10.17151/hpsal.2021.26.1.11 · Cited by 8
“Epidemiological studies have identified high body mass index (BMI) as a risk factor for an expanding group of chronic diseases (6-7).”
BackgroundGasparri, C., Perna, S., Peroni, G., Riva, A., Petrangolini, G., Faliva, M. A., Naso, M., & Rondanelli, M. (2022) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-022-01412-8 · Cited by 5
“It is associated with greater risk of developing several chronic diseases including cardiovascular disease [3, 4], diabetes mellitus [3],”
BackgroundDing, J., Chen, J., Zhou, J., Jiang, Z., Xiang, D., & Xing, W. (2023) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2023.2228518 · Cited by 5
“Each 10-mmHg increase in systolic blood pressure (SBP) is associated with a 45% higher risk of ischemic heart disease and an approximately 65% higher risk of stroke in patients aged 55–64 years (11,12).”
BackgroundZhang, M., Sun, L., Wu, X., Qin, Y., Lin, M., Ding, X., Zhu, W., Jiang, Z., Jin, S., Leng, C., et al. (2023) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2023.12.002 · Cited by 7
Luconi, E., Tosi, M., Boracchi, P., Colonna, I., Rappocciolo, E., Ferraretto, A., & Lorenzini, E. C. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05325-1 · Cited by 6
“Higher-than-optimal BMI was estimated to cause 5 millions deaths worldwide from NCD [9, 10].”
Background
Metadata
- Authors
- Singh, G. M., Danaei, G., Farzadfar, F., Stevens, G. A., Woodward, M., Wormser, D., Kaptoge, S., Whitlock, G., Qiao, Q., Lewington, S., Di Angelantonio, E., vander Hoorn, S., Lawes, C. M. M., Ali, M. K., Mozaffarian, D., Ezzati, M., Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group; Asia-Pacific Cohort Studies Collaboration (APCSC), (DECODE), D. E. C. A. O. D. C. I. E., Emerging Risk Factor Collaboration (ERFC), & Prospective Studies Collaboration (PSC)
- Affiliations
- Harvard University (US)
- Tehran University of Medical Sciences (IR)
- World Health Organization (CH)
- The University of Sydney (AU)
- University of Cambridge (GB)
- University of Oxford (GB)
- University of Helsinki (FI)
- University of Auckland (NZ)
- Emory University (US)
- Brigham and Women's Hospital (US)
- MRC Centre for Environment and Health (GB)
- Corresponding author
- Ezzati, Majid
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-07-30
- Volume
- 8
- Issue
- 7
- Pages
- e65174
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3728292
- OpenAlex
- W2122520859
- Cited by
- 772
- References
- 67
- Citations by year
- 2026: 29 · 2025: 64 · 2024: 84 · 2023: 87 · 2022: 103 · 2021: 86 · 2020: 85 · 2019: 66 · 2018: 43 · 2017: 49 · 2016: 41 · 2015: 18 · 2014: 16 · 2013: 1
- FWCI
- 19.82
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by)
- Pure Amsterdam UMC (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- Monash University Research Portal (Monash University) (acceptedVersion, other-oa)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Site cant be reached (submittedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- OPUS (Augsburg University) (submittedVersion, cc-by)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- World Health Organization
- National Institute for Health and Care Research (NF-SI-0512-10165)
- British Heart Foundation (RG/08/013/25942, RG/07/008/23674, RG/08/014/24067)
- Imperial College London
- Imperial College Healthcare NHS Trust
- Medical Research Council (MR/K005901/1, MR/L003120/1)
- Economic and Social Research Council (ES/F02679X/1)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK007703., T32DK007703)
- National Institute of Environmental Health Sciences (P30ES005605)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Keywords
- metabolic risk factors, cardiovascular disease, diabetes mellitus, systolic blood pressure, total cholesterol, fasting blood glucose, body mass index, ischemic heart disease, hypertensive heart disease, stroke, sex differences, pooled cohort analysis, relative risk, effect modification by age
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Blood Glucose, Blood Pressure, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Risk, Sex Factors, Body Mass Index, Patient Outcome Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.